1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMD 121974-011, EORTC 26071-22072, NCT00689221
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-9911, JHOC-NABTT-9911, NCT00006093
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NABTT-0306 CDR0000368451, U01CA062475, ABTC-0306, NABTT-0306, NCT00085254
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 200052-013, NCT00705016
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 200037-014, EudraCT Number: 2008-004148-35, NCT00842712
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2003-0988, P30CA016672, MDA-2003-0988, NCI-6387, CDR0000360886, 6387, NCT00082875
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 50 and over
Sponsor: NCI
Protocol IDs: MDA-2003-1007, 6384, NCI-6384, NCT00089388
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-0408014-01, EMD-121974-009, MERCK-EMD-121974-009, NCT0093964
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTC-0302, NABTC-03-02, NCT00112866
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000438708, P30CA046592, CCUM-2004-045, NCI-6735, 6735, NCT00121238
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000595623, COG-ACNS0621, ACNS0621, NCT00679354
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMD 121974-012, NCT00813943
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000409571, CCUM-2004-030, NCI-6372, UCSF-045512, UCSF-H45860-26715-01B, 6372, NCT00103337
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: AMC-023, NCT00006222
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCHSC-001096, NCI-3358, 3358, NCT00022113
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-12774A, NCI-6362, 6362, NCT00077155
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 9909-40; T99-0076, IUMC-9909-40, NCI-T99-0076, T99-0076, NCT00004258
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000305859, PBTC-012, NCT00063973
|
|
19.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-09-259-A, 8313, NCT01122888
|
Mobile | Español
